Patient
Type |
|
Why |
Patients
with COPD of varying severity
|
|
Patients diagnosed with all severities
of COPD were included in the development and validation of
the CAT.
|
Patients
with different reading abilities
|

|
The CAT uses a simple scale and basic
language making it readily interpretable and usable for patients.
|
Patients being treated outside of the UK or US
|

|
The development of the CAT included data
from patients in the US and Europe, and the CAT Development
Steering Group believe that it is globally applicable. A
validation study is currently ongoing in China.
|
Patients
whose first language isn’t English
|

|
The simplicity of the CAT means that
it can be used by patients with even a very basic English
language. In the future, the CAT will also be translated
into other languages.
|
Reference
- The COPD Assessment Test
healthcare professional user guide: expert guidance on frequently asked questions. Jones PW, Jenkins C, Bauerle O (on behalf of the CAT Development Steering Group).
Page Last Updated: April 25, 2012
COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline group of companies.
©2009 GlaxoSmithKilne group of companies. All rights reserved.